UNSPSC 51294512: Paroxetine

This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 41VRH5220H. European Medicines Agency schedules Paroxetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09631MIG. Paroxetine generally arises in the molecular formula C19H20FNO3.

UNSPSC 51294512 Paroxetine is a Commodity code that nominally refers to a specific antidepressant pharmaceutical; however, the recent state and local activity tracked under this code does not align with paroxetine procurement. The single recent opportunity posted under this code is Seminole County, Florida's IFB60459723LAS, which solicits 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health delivery — a scope entirely unrelated to paroxetine. The mismatch suggests either a coding error in the opportunity record or that this Commodity code sees minimal actual paroxetine-related purchasing from state and local jurisdictions. No other recent solicitations appear in the opportunity stream for this code.

The Seminole County naloxone procurement is structured as a competitive IFB with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023, and a two-year initial term plus one-year renewal option. Vendors must provide unit pricing, electronic bid submission, E-Verify compliance, and standard insurance coverage; FEMA funding introduces Clean Air Act and Federal Water Pollution Control Act compliance obligations. The opportunity appears isolated within the recent dataset, and the code itself shows no relevant paroxetine-related activity in state and local markets today.